YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
7.86
-0.29 (-3.56%)
Mar 9, 2026, 3:31 PM EDT - Market open
YD Bio Market Cap
YD Bio has a market cap or net worth of $552.71 million as of March 9, 2026. Its market cap has increased by 1,116.91% in one year.
Market Cap
552.71M
Enterprise Value
552.42M
1-Year Change
1,116.91%
Ranking
Category
Stock Price
$7.86
Market Cap Chart
Since December 23, 2020, YD Bio's market cap has increased from $148.36M to $552.71M, an increase of 272.56%. That is a compound annual growth rate of 28.76%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LB Pharmaceuticals | 601.61M |
| enGene Holdings | 581.47M |
| Design Therapeutics | 572.49M |
| Larimar Therapeutics | 566.84M |
| MeiraGTx Holdings | 563.44M |
| Verastem | 560.39M |
| Alpha Tau Medical | 546.54M |
| Fulcrum Therapeutics | 544.12M |